Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Boehringer Ingelheim
Boehringer Ingelheim
BeiGene
Korea University Anam Hospital
BeyondBio Inc.
ImmunityBio, Inc.
Case Comprehensive Cancer Center
ImmunityBio, Inc.
Georgetown University
Zhejiang Cancer Hospital
National Cancer Institute, Naples
ChineseAMS
Silverback Therapeutics
UNC Lineberger Comprehensive Cancer Center
ChineseAMS
M.D. Anderson Cancer Center
China Medical University, China
Swiss Cancer Institute
Swiss Cancer Institute
Duke University
Western Regional Medical Center
Shanghai University of Traditional Chinese Medicine
Ottawa Hospital Research Institute
Roswell Park Cancer Institute
Roswell Park Cancer Institute
University of Cologne
Swiss Cancer Institute
Lund University Hospital
Chugai Pharmaceutical
AstraZeneca
Aronex Pharmaceuticals